BW A256C, a Chemically Novel Class 1 Antiarrhythmic Agent. A Comparison of in Vitro and in Vivo Activity With Other Class 1 Antiarrhythmic Agents

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1986.tb10209.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Pharmacological Defibrillation and Its Mechanism in Atrial Fibrillation. The Efficacy of a Pure Class III Agent Dofetilide as Compared With Class I Antiarrhythmic Agents.

Japanese Journal of Electrocardiology
1998English

Kinetics of Rate-Dependent Slowing of Intraventricular Conduction by the Class Ib Antiarrhythmic Agent Tocainide in Vivo

British Journal of Pharmacology
Pharmacology
1993English

Effects of Sematilide, a Novel Class III Antiarrhythmic Agent, on Delayed Rectifier K+ Current in Guinea Pig Atrial Myocytes.

The Japanese Journal of Pharmacology
1996English

Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents

English

Recent Findings on the Dromotropic Actions of the Class III Antiarrhythmic Agents.

Folia Pharmacologica Japonica
Pharmacology
2002English

Antiarrhythmic Effects of the Class 1c Antiarrhythmic Drug, Flecainide, on Canine Ventricular Arrhythmia Models.

Japanese Heart Journal
1989English

Absence of Effects of Class III Antiarrhythmic Agents on Cloned Cardiac K Channels.

The Japanese Journal of Pharmacology
1993English

Propafenone: A Promising New Antiarrhythmic Agent

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1990English

Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy